Cindy Blatter

ZHAW Life Sciences und Facility Management
Fachgruppe Organische Chemie und Medizinalchemie

Netzwerk

Nasi, S., Ehirchiou, D., Blatter, C., Chobaz, V., Germann, S., Brandenberger, A., Bommeli, E., Uchikawa, E., Cirino, G., Riedl, R., So, A., & Busso, N. (2025). Allosteric activators of cystathionine γ lyase to augment endogenous hydrogen sulfide and inhibit pathologic calcification. Pharmacological Research, 219(107869). https://doi.org/10.1016/j.phrs.2025.107869
Pliatsika, D., Blatter, C., & Riedl, R. (2024). Targeted protein degradation : current molecular targets, localization, and strategies. Drug Discovery Today, 29(11), 104178. https://doi.org/10.1016/j.drudis.2024.104178

Ehirchiou, D., Chirayath, T., Nasi, S., Chobaz, V., Riedl, R., Blatter, C., Germann, S., Brandenberger, A., Bommeli, E., Busso, N., & So, A. (2025). Positive allosteric modulators (PAMS) of cystathionine gamma lyase (CSE) increase hydrogen sulfide (H2S) and inhibit NLRP3 activation [Conference presentation]. Annals of the Rheumatic Diseases, 84(Supplement 1), 116–117. https://doi.org/10.1016/j.ard.2025.05.154
Ehirchiou, D., Nasi, S., Chobaz, V., Riedl, R., Germann, S., Brandenberger, A., Bommeli, E., Blatter, C., Cirino, G., So, A., & Busso, N. (2025). Development of allosteric activators of cystathionine γ lyase (CSE) to augment hydrogen sulfide (H2S) and inhibit pathologic cartilage calcification [Conference presentation]. Annals of the Rheumatic Diseases, 84(Supplement 1), 112–113. https://doi.org/10.1016/j.ard.2025.05.149
Ehirchiou, D., Nasi, S., Chobaz, V., Riedl, R., Blatter, C., Germann, S., Brandenberger, A., Bommeli, E., So, A., & Busso, N. (2025). Development of allosteric activators of cystathionine γ lyase (CSE) to augment hydrogen sulfide (H2S) and inhibit pathologic cartilage calcification [Conference presentation]. Osteoarthritis and Cartilage, 33, S452. https://doi.org/10.1016/j.joca.2025.02.660